NovoCure Ownership | Who Owns NovoCure?

Overview Forecast RevenueFinancials Chart Transcripts

NovoCure Ownership Summary

NovoCure is owned by 81.75% institutional investors, 9.64% insiders, and 8.61% retail investors. Fmr is the largest institutional shareholder, holding 14.99% of NVCR shares. American Funds SMALLCAP World A is the top mutual fund, with 7.34% of its assets in NovoCure shares.

NVCR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	NovoCure	81.75%	9.64%	8.61%
Sector	Healthcare Stocks	56.95%	9.28%	33.77%
Industry	Medical Instruments & Supplies Stocks	45.87%	12.68%	41.45%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	16.23M	14.99%	$483.66M
Blackrock funding, inc. /de	13.03M	12.03%	$388.19M
Blackrock	12.13M	11.31%	$207.83M
Vanguard group	11.80M	10.90%	$351.52M
Capital investors	8.87M	8.20%	$264.44M
Capital world investors	4.82M	4.45%	$143.50M
State street	3.01M	2.80%	$51.49M
Soleus capital management	2.74M	2.53%	$81.64M
Geode capital management	2.40M	2.22%	$71.54M
T. rowe price investment management	1.69M	1.56%	$50.38M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Superstring capital management lp	286.97K	7.41%	$8.55M
Invus financial advisors	350.88K	6.74%	$6.01M
Soleus capital management	2.74M	5.13%	$81.64M
Nordwand advisors	312.15K	3.83%	$9.30M
Palo alto investors lp	814.19K	3.76%	$24.26M
Taylor frigon capital management	143.44K	2.16%	$4.27M
Granite investment partners	686.73K	0.88%	$20.46M
Birchview capital, lp	31.00K	0.75%	$923.80K
Essex investment management	121.83K	0.65%	$3.63M
Emerald advisers	547.56K	0.63%	$16.32M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	12.13M	0.00%	3.05M
Soleus capital management	2.74M	5.13%	2.74M
Capital investors	8.87M	0.05%	951.14K
Granite investment partners	686.73K	0.88%	686.73K
Emerald advisers	547.56K	0.63%	547.56K

Top Sellers

Holder	Shares	% Assets	Change
Nordwand advisors	312.15K	3.83%	-2.72M
T. rowe price investment management	1.69M	0.03%	-1.12M
Morgan stanley	806.52K	0.00%	-950.12K
Price t rowe associates inc /md/	1.68M	0.01%	-638.38K
Marshall wace, llp	270.95K	0.01%	-508.72K

New Positions

Holder	Shares	% Assets	Change	Value
Granite investment partners	686.73K	0.88%	686.73K	$20.46M
Emerald advisers	547.56K	0.63%	547.56K	$16.32M
Silvercrest asset management group	385.41K	0.05%	385.41K	$6.60M
Emerald mutual fund advisers trust	325.25K	0.59%	325.25K	$9.69M
Adage capital partners gp	200.00K	0.01%	200.00K	$5.96M

Sold Out

Holder	Change
Salem investment counselors	-4.00
Mather group, llc.	-15.00
Central trust	-18.00
Raleigh capital management	-26.00
Rise advisors	-30.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	249	5.51%	88,494,339	-4.72%	81	1.11%	117	27.17%	74	-
Sep 30, 2024	234	-6.02%	92,882,050	-0.04%	85	1.14%	91	-26.61%	73	7.35%
Jun 30, 2024	247	-4.26%	92,913,219	4.09%	86	1.23%	123	-1.60%	67	6.35%
Mar 31, 2024	258	7.05%	89,258,298	-1.39%	83	1.17%	125	-2.34%	63	12.50%
Dec 31, 2023	241	-5.12%	90,513,161	-0.77%	84	1.15%	128	5.79%	56	-11.11%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
American Funds SMALLCAP World A	7.94M	7.34%	1.42M
Fidelity Growth Compy Commingled Pl S	7.65M	7.07%	74.37K
Fidelity Growth Compy Commingled Pl O	7.46M	6.89%	-
Fidelity Growth Company Fund	5.25M	4.85%	-38.51K
Vanguard Total Stock Mkt Idx Inv	3.39M	3.13%	3.53K
American Funds Growth Fund of Amer A	3.30M	3.05%	-
Capital Group Growth Fnd of Amer Comp	3.30M	3.05%	-
BioPharma Credit Ord	2.92M	2.70%	2.92M
iShares Russell 2000 ETF	2.89M	2.67%	-21.95K
Vanguard Small Cap Index	2.76M	2.55%	21.33K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 11, 2025	Paravasthu Mukund	Chief Operating Officer	Sell	$57.91K
Nov 02, 2024	Paravasthu Mukund	Chief Operating Officer	Sell	$734.18
Oct 31, 2024	Puri Michal Nath	Chief Human Resources Officer	Sell	$12.79K
Nov 01, 2024	Leonard Frank X	EVP, Pres., Novocure Oncology	Sell	$9.53K
Nov 01, 2024	Paravasthu Mukund	Chief Operating Officer	Sell	$2.54K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	4
2024 Q3	-	1
2024 Q2	-	3
2024 Q1	-	6

NVCR Ownership FAQ

Who Owns NovoCure?

NovoCure shareholders are primarily institutional investors at 81.75%, followed by 9.64% insiders and 8.61% retail investors. The average institutional ownership in NovoCure's industry, Medical Instruments & Supplies Stocks, is 45.87%, which NovoCure exceeds.

Who owns the most shares of NovoCure?

NovoCure’s largest shareholders are Fmr (16.23M shares, 14.99%), Blackrock funding, inc. /de (13.03M shares, 12.03%), and Blackrock (12.13M shares, 11.31%). Together, they hold 38.34% of NovoCure’s total shares outstanding.

Does Blackrock own NovoCure?

Yes, BlackRock owns 11.31% of NovoCure, totaling 12.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 207.83M$. In the last quarter, BlackRock increased its holdings by 3.05M shares, a 33.55% change.

Who is NovoCure’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is NovoCure’s biggest shareholder by percentage of total assets invested, with 7.41% of its assets in 286.97K NovoCure shares, valued at 8.55M$.

Who is the top mutual fund holder of NovoCure shares?

American Funds SMALLCAP World A is the top mutual fund holder of NovoCure shares, with 7.34% of its total shares outstanding invested in 7.94M NovoCure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools